Cargando…

Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report

INTRODUCTION: Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parathyroid gland adenoma identified by localisation studies is minimally invasive fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pislar, Nina, Hocevar, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318857/
https://www.ncbi.nlm.nih.gov/pubmed/34336200
http://dx.doi.org/10.1016/j.amsu.2021.102577
_version_ 1783730334045569024
author Pislar, Nina
Hocevar, Marko
author_facet Pislar, Nina
Hocevar, Marko
author_sort Pislar, Nina
collection PubMed
description INTRODUCTION: Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parathyroid gland adenoma identified by localisation studies is minimally invasive focused parathyroidectomy. If unsuccessful, bilateral neck exploration is recommended. CASE PRESENTATION: We report the case of hypercalcaemia and ostheoporosis in a 63–year -old woman with a history of sarcoidosis and suspected primary hyperparathyroidism. Localisation studies for parathyroid adenoma were inconclusive due to active cervical and mediastinal granulomatous lymph nodes. Sarcoidosis was treated with corticosteroids but hypercalcaemia persisted. Focused parathyroidectomy was attempted with intraoperative parathyroid hormone measurement but an increase in parathyroid hormone levels was observed. However, with high clinical probability of a successfully removed adenoma and frozen section evaluation, we decided not to proceed with bilateral neck exploration. Serum parathyroid hormone and calcium levels dropped accordingly the following day. CLINICAL DISCUSSION: We explored all possible underlying mechanisms for persistent elevated parathyroid hormone level described in literature. CONCLUSION: We conclude that Wisconsin Criteria with intraoperative parathyroid hormone measured 20 minutes after adenoma removal should be applied in such cases.
format Online
Article
Text
id pubmed-8318857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83188572021-07-31 Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report Pislar, Nina Hocevar, Marko Ann Med Surg (Lond) Case Report INTRODUCTION: Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parathyroid gland adenoma identified by localisation studies is minimally invasive focused parathyroidectomy. If unsuccessful, bilateral neck exploration is recommended. CASE PRESENTATION: We report the case of hypercalcaemia and ostheoporosis in a 63–year -old woman with a history of sarcoidosis and suspected primary hyperparathyroidism. Localisation studies for parathyroid adenoma were inconclusive due to active cervical and mediastinal granulomatous lymph nodes. Sarcoidosis was treated with corticosteroids but hypercalcaemia persisted. Focused parathyroidectomy was attempted with intraoperative parathyroid hormone measurement but an increase in parathyroid hormone levels was observed. However, with high clinical probability of a successfully removed adenoma and frozen section evaluation, we decided not to proceed with bilateral neck exploration. Serum parathyroid hormone and calcium levels dropped accordingly the following day. CLINICAL DISCUSSION: We explored all possible underlying mechanisms for persistent elevated parathyroid hormone level described in literature. CONCLUSION: We conclude that Wisconsin Criteria with intraoperative parathyroid hormone measured 20 minutes after adenoma removal should be applied in such cases. Elsevier 2021-07-17 /pmc/articles/PMC8318857/ /pubmed/34336200 http://dx.doi.org/10.1016/j.amsu.2021.102577 Text en © 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Pislar, Nina
Hocevar, Marko
Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
title Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
title_full Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
title_fullStr Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
title_full_unstemmed Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
title_short Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
title_sort intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318857/
https://www.ncbi.nlm.nih.gov/pubmed/34336200
http://dx.doi.org/10.1016/j.amsu.2021.102577
work_keys_str_mv AT pislarnina intraoperativeparathormoneincreaseafterfocusedparathyroidectomyinapatientwithsarcoidosiscasereport
AT hocevarmarko intraoperativeparathormoneincreaseafterfocusedparathyroidectomyinapatientwithsarcoidosiscasereport